A Prostate Antigen in Sera of Prostatic Cancer Patients

Overview

Journal Cancer Res

Specialty Oncology

Date 1980 Jul 1

PMID 7388802

Citations 40

Authors

L D Papsidero

M C Wang

L A Valenzuela

G P Murphy

T M Chu

Affiliations

Soon will be listed here.

Abstract

A prostate antigen has been detected by a rocket immunoelectrophoresis technique in 17 of 219 sera obtained from patients with advanced prostatic cancer. Sera from 175 patients with nonprostatic cancers, including those with late-stage disease of the breast, lung, colon, rectum, stomach, and pancreas, were antigen negative as were 20 samples each from normal adults and age-matched males. Antigen in sera showed immunological identity with antigen in prostate tissue as determined by immunoprecipitation peak enhancement experiments. Using antibody affinity chromatography and radioimmunoprecipitation techniques, the antigen in sera was purified and subjected to sodium dodecyl sulfate electrophoresis; it exhibited a molecular weight of approximately 36,000, similar to that of antigen isolated from prostatic tissue.

Citing Articles

Simple Binding and Dissociation of a Sialoglycoprotein Using Boronic Acid-Modified Functional Interfaces on Microparticles.

Horiguchi Y, Yasuura M, Ashiba H, Tan Z, Fukuda T Sensors (Basel). 2024; 24(4).

PMID: 38400238 PMC: 10891811. DOI: 10.3390/s24041080.

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium.

Beyer K, Leenen R, Venderbos L, Helleman J, Denijs F, Bramer W J Pers Med. 2024; 14(1).

PMID: 38248785 PMC: 10819943. DOI: 10.3390/jpm14010084.

Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care.

Tu S, Chen J, Singh S, Aydin A, Gokden N, Tam N Cancers (Basel). 2023; 15(23).

PMID: 38067237 PMC: 10705798. DOI: 10.3390/cancers15235533.

A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers.

Shinawi T, Nasser K, Moradi F, Mujalli A, Albaqami W, Almukadi H Front Genet. 2022; 13:1066118.

PMID: 36468011 PMC: 9708707. DOI: 10.3389/fgene.2022.1066118.

Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future.

van Poppel H, Albreht T, Basu P, Hogenhout R, Collen S, Roobol M Nat Rev Urol. 2022; 19(9):562-572.

PMID: 35974245 DOI: 10.1038/s41585-022-00638-6.